Šalis: Naujoji Zelandija
kalba: anglų
Šaltinis: Medsafe (Medicines Safety Authority)
Glycopyrronium bromide 0.5 mg/mL; Neostigmine metilsulfate 2.5 mg/mL
Boucher & Muir (NZ) Ltd t/a Mercury Pharma (NZ)
Glycopyrronium bromide 0.5 mg/mL
Solution for injection
Active: Glycopyrronium bromide 0.5 mg/mL Neostigmine metilsulfate 2.5 mg/mL Excipient: Citric acid Citric acid monohydrate Dibasic sodium phosphate dodecahydrate Sodium hydroxide Water for injection
Prescription
PCAS Finland Oy
Reversal of residual non-depolarising (competitive) neuromuscular block.
Package - Contents - Shelf Life: Ampoule, glass, Type I - 10 dose units - 24 months from date of manufacture stored at or below 25°C protect from light
2012-08-30